Advancing a Gene Therapy for a Rare and Fatal CNS Disorder

Samiah Al-Zaidy, vice president of clinical development for Passage Bio, discusses the rare lysosomal storage disorder GM1 gangliosidosis, the company’s experimental therapy to treat the condition, and what’s known about the therapy from work that’s been done to date.